Advertisement

Improvement in the management of patients with Clostridium difficile associated diarrhoea following changes to the wording of laboratory reports

Published:March 09, 2017DOI:https://doi.org/10.1016/j.jhin.2017.03.007
      Clinical manifestations of Clostridium difficile infection (CDI) range from asymptomatic colonization through mild diarrhoea to life-threatening pseudomembranous colitis. Management of patients with potential CDI is implemented based on clinical findings combined with laboratory testing. At Royal Berkshire NHS Foundation Trust (RBFT), diarrhoeal stool samples from hospital patients (Bristol stool chart type 5–7, not attributable to any underlying clinical condition or medication) above 2 years of age are tested for C. difficile [
      • Department of Health, Health Protection Agency
      Clostridium difficile infection: how to deal with the problem.
      ,
      • Lewis S.J.
      • Heaton K.W.
      Stool form scale as a useful guide to intestinal transit time.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Department of Health, Health Protection Agency
        Clostridium difficile infection: how to deal with the problem.
        DoH, London2008
        • Lewis S.J.
        • Heaton K.W.
        Stool form scale as a useful guide to intestinal transit time.
        Scand J Gastroenterol. 1997; 32: 920-924
        • Department of Health
        Updated guidance on the diagnosis and reporting of Clostridium difficile.
        DoH, London2012
        • Bartlett J.G.
        Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhoea and colitis.
        Johns Hopkins Med J. 1981; 149: 6-9